✦ LIBER ✦

Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study

✍ Scribed by Luca S. Belli; Riccardo Volpes; Ivo Graziadei; Stefano Fagiuoli; Peter Starkel; Patrizia Burra; Alberto B. Alberti; Bruno Gridelli; Wolfgang Vogel; Luisa Pasulo; Eleonora De Martin; Maria Guido; Luciano De Carlis; Jan Lerut; Umberto Cillo; Andrew K. Burroughs; Giovambattista Pinzello

Book ID: 119230082
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 331 KB
Volume: 44
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2012.01.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[87] EFFICACY OF ANTIVIRAL THERAPY ON DI

[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDY

✍ J.A. Carrion; M. Navasa; M. Garcia-Retortillo; J.C. Garcia-Pagan; G. Crespo; M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Fibrosis Progression and the Pros and Co

Fibrosis Progression and the Pros and Cons of Antiviral Therapy for Hepatitis C Virus Recurrence After Liver Transplantation: A Review

✍ E. De Martin; M. Senzolo; M. Gambato; G. Germani; A. Vitale; F.R. Russo; P. Burr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Non-invasive assessment of liver fibrosi

Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study

✍ Jean-Pierre Zarski; Nathalie Sturm; Hervé Desmorat; Pascal Melin; Jean-Jacques R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Liver stiffness identifies two different

Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation

✍ José A. Carrión; Ferran Torres; Gonzalo Crespo; Rosa Miquel; Juan-Carlos García- 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

Significant liver fibrosis (F >or= 2) and portal hypertension (hepatic venous pressure gradient [HVPG] >or= 6 mmHg) at 1 year after liver transplantation (LT) identify patients with severe hepatitis C recurrence. We evaluated whether repeated liver stiffness measurements (LSM) following LT can discr

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub

Hepatitis C recurrence and fibrosis prog

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: A single-center study of 289 patients

✍ Maximilian Schmeding; Ulf Peter Neumann; Gero Puhl; Marcus Bahra; Ruth Neuhaus; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

Today, hepatitis C virus (HCV) is the leading cause for liver transplantation (LT) and viral recurrence is almost universal. It has been suggested that viral replication within the transplanted tissue might be increased in organs of reduced size such as LD grafts. In the current literature the data